Lv51
1533 积分 2022-12-05 加入
Validation of a modified Caprini risk assessment model in lung cancer patients undergoing surgery: Results of a multicenter cross‐sectional observational study
19天前
已完结
Subclinical venous thromboembolism after pulmonary resection for lung cancer: an observational study
19天前
已完结
Khorana risk score in lung cancer patients treated with immune checkpoint inhibitors: a real-world study
19天前
已完结
Development and Validation of a Modified Khorana Score for Predicting Venous Thromboembolism in Newly Diagnosed Stage IV Lung Cancer
20天前
已完结
Venous thrombotic events and impact on outcomes in patients treated with first-line single-agent pembrolizumab in PD-L1 ≥ 50% advanced non small cell lung cancer
20天前
已完结
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
20天前
已完结
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
20天前
已完结
COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study
20天前
已完结
Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
20天前
已完结
A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer
20天前
已完结
皖公网安备34019202002308
